3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hepatitis C
4
Carcinoma, Hepatocellular
3
Respiratory Tract Infections
2
Leukemia, Myeloid, Acute
2
Respiratory Syncytial Virus Infections
1
Recurrence
1
Pneumonia
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Liver Neoplasms
1
Liver Diseases
1
Infections
1
Hepatitis
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Bronchiolitis Obliterans Syndrome
1
Interventions
Whole-Body Irradiation
4
Sulindac
4
Peripheral Blood Stem Cell Transplantation
4
Methotrexate
4
fludarabine phosphate
3
Selenium
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
Cetuximab
3
Biopsy
3
Tacrolimus
2
Sirolimus
2
Radiotherapy, Intensity-Modulated
2
Polymerase Chain Reaction
2
Mycophenolic Acid
2
Melphalan
2
Gene Expression Profiling
2
Etoposide
2
Darbepoetin alfa
2
Cyclosporine
2
Cyclophosphamide
2
Cisplatin
2
Busulfan
2
Aspirin
2
Aminolevulinic Acid
2
Albumin-Bound Paclitaxel
2
vandetanib
1
ruxolitinib
1
polyphenon E
1
perillyl alcohol
1
peginterferon alfa-2b
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Precancerous Conditions
×
Ribavirin
×
Clear all
No trials found.